Microfluidic assay of hemophilic blood clotting: Distinct deficits in platelet and fibrin deposition at low factor levels

Journal of Thrombosis and Haemostasis

Volumn 12, Issue 2, 2014, Pages 147-158

  Colace, T V ^a   Fogarty, P F ^b   Panckeri, K A ^b   Li, R ^a   Diamond, S L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Blood coagulation; Hemophilia; Hemostasis; Microfluidics; Platelets

Indexed keywords

FIBRILLAR COLLAGEN; FIBRIN; THROMBIN; TRYPSIN INHIBITOR;

ARTICLE; BLEEDING; BLOOD ANALYSIS; BLOOD CLOTTING; BLOOD CLOTTING FACTOR 11 DEFICIENCY; BLOOD DONOR; CLINICAL ARTICLE; CONTROLLED STUDY; FIBRIN DEPOSITION; FIBRIN FORMATION; HEMODYNAMICS; HEMOPHILIA A; HEMOPHILIA B; HEMOSTASIS; HUMAN; MAIZE; MICROFLUIDIC ANALYSIS; MICROFLUIDICS; PRIORITY JOURNAL; PROTHROMBIN TIME; SHEAR RATE; THROMBOCYTE ACTIVATION;

BLOOD COAGULATION; HEMOPHILIA; HEMOSTASIS; MICROFLUIDICS; PLATELETS;

BLOOD COAGULATION; BLOOD PLATELETS; FIBRIN; HEMOPHILIA A; HUMANS; MICROFLUIDICS;

EID: 84893580012     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12457     Document Type: Article

References (23)

1. Flamm MH, Colace TV, Chatterjee MS, Jing H, Zhou S, Jaeger D, Brass LF, Sinno T, Diamond SL. Multiscale prediction of patient-specific platelet function under flow. Blood 2012; 120: 190-8.
2. Li R, Fries S, Li X, Grosser T, Diamond SL. Microfluidic assay of platelet deposition on collagen by perfusion of whole blood from healthy individuals taking aspirin. Clin Chem 2013; 59: 1195-204.
3. Neeves KB, Onasoga AA, Hansen RR, Lilly JJ, Venckunaite D, Sumner MB, Irish AT, Brodsky G, Manco-Johnson MJ, Di Paola JA. Sources of variability in platelet accumulation on type 1 fibrillar collagen in microfluidic flow assays. PLoS ONE 2013; 8: e54680.
4. Colace TV, Tormoen GW, McCarty OJT, Diamond SL. Microfluidics and coagulation biology. Annu Rev Bioeng 2013; 15: 283-303.
5. Colace TV, Jannielle J, Diamond SL. Relipidated tissue factor linked to collagen surfaces potentiates platelet adhesion and fibrin formation in a microfluidic model of vessel injury. Bioconjug Chem 2011; 22: 2104-9.
6. Okorie UM, Denney WS, Chatterjee MS, Neeves KB, Diamond SL. Determination of surface tissue factor thresholds that trigger coagulation at venous and arterial shear rates: amplification of 100 fM circulating tissue factor requires flow. Blood 2008; 111: 3507-13.
7. Colace TV, Muthard RW, Diamond SL. Thrombus growth and embolism on tissue factor-bearing collagen surfaces under flow: role of thrombin with and without fibrin. Arterioscler Thromb Vasc Biol 2012; 32: 1466-76.
8. Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 1989; 134: 1087-97.
9. Fleck RA, Vijaya Mohan Rao L, Rapaport SI, Varki N. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb Res 1990; 57: 765-81.
10. Carcao MD, Marijke van den Berg H, Ljung R, Mancuso ME. Correlation between phenotype and genotype in a large unselected cohort of children with severe hemophilia A. Blood 2013; 121: 3946-52.
11. Santagostino E, Mancuso ME, Tripodi A, Chantarangkul V, Clerici M, Garagiola I, Mannucci PM. Severe hemophilia with mild bleeding phenotype: molecular characterization and global coagulation profile. J Thromb Haemost 2010; 8: 737-43.
12. Sorensen B, Ingerslev J. Whole blood clot formation phenotypes in hemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa. J Thromb Haemost 2004; 2: 102-10.
13. van Den Berg HM, De Groot PHG, Fischer K. Phenotypic heterogeneity in severe hemophilia. J Thromb Haemost 2007; 5: 151-6.
14. Young G, Sorensen B, Dargaud Y, Negrier C, Brummel-Ziedins K, Key NS. Thrombin generation and whole blood viscoelastic assays in the management of hemophilia: current state of art and future perspectives. Blood 2013; 121: 1944-50.
15. Maloney SF, Brass LF, Diamond SL. P2Y12 or P2Y1 inhibitor reduce platelet deposition in a microfluidic model of thrombosis while apyrase lacks efficacy under flow conditions. Integr Biol 2010; 2: 153-220.
16. Neeves KB, Maloney SF, Fong KP, Schmaier AA, Kahn ML, Brass LF, Diamond SL. Microfluidic focal thrombosis model for measuring murine platelet deposition and stability: PAR4 signaling enhances shear-resistance of platelet aggregates. J Thromb Haemost 2008; 6: 2193-301.
17. Chatterjee MS, Denney WS, Jing H, Diamond SL. Systems biology of coagulation initiation: kinetics of thrombin generation in resting and activated human blood. PLoS Comput Biol 2010; 6: e1000950.
18. Welsh JD, Colace TV, Muthard RW, Stalker TJ, Brass LF, Diamond SL. Platelet-targeting sensor reveals thrombin gradients within blood clots forming in microfluidic assays and in mouse. J Thromb Haemost 2012; 10: 2344-53.
19. van der Meijden PEJ, Munnix ICA, Auger JM, Govers-Riemslag JWPG, Cosemans JMEM, Kuijpers MJE, Spronk HM, Watson SP, Renne T, Heemskerk JWM. Dual role of collagen in factor XII-dependent thrombus formation. Blood 2009; 114: 881-90.
20. Heemskerk JWM, Bevers EM, Lindhout T. Platelet activation and blood coagulation. Thromb Haemost 2002; 88: 185-93.
21. Neeves KB, Illing DA, Diamond SL. Thrombin flux and wall shear rate regulate fibrin fiber deposition state during polymerization under flow. Biophys J 2010; 98: 1344-52.
22. Blanchette VS, Manco-Johnson M, Santagostino E, Ljung R. Optimizing factor prophylaxis for the haemophilia population: where do we stand? Haemophlia 2004; 10: 97-104.
23. Collins PW, Blanchette VS, Fischer K, Bjorkman S, Oh M, Fritsch S, Schroth P, Spotts G, Astermark J, Ewenstein B, on behalf of the rAHF-PFM study group. Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A. J Thromb Haemost 2009; 7: 413-20.